Doubtful buddy... Lilly is well aware that the best representatives reside within Diabetes (probably no cuts), Cardio (cuts but top reps- will try to keep as many as possible with reallocations), and Neuroscience (best most tenured representatives with best CVM scores- will be reallocated for sure when possible). MSK and Mens health might see some unfortunate cuts as we don't have our best resources within those divisions.
Our Vet business is expanding and we will be reallocating some of our treasured resources to that division.
The sad thing is our Oncology division needed more cuts but Lilly always tries to do the right thing by saving people. Well known from upper management that Oncology is weak within our organization. Trust me the only thing good about Lilly Oncology is the experience but it actually hurts you in the long run because every other company knows we are the bottom of the barrel in terms of talented reps! No one at Amgen is thinking "we need to hire the Lilly rep"...